These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17614097)
1. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. Jones M; Peden AH; Prowse CV; Gröner A; Manson JC; Turner ML; Ironside JW; MacGregor IR; Head MW J Pathol; 2007 Sep; 213(1):21-6. PubMed ID: 17614097 [TBL] [Abstract][Full Text] [Related]
2. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Jones M; Peden AH; Yull H; Wight D; Bishop MT; Prowse CV; Turner ML; Ironside JW; MacGregor IR; Head MW Transfusion; 2009 Feb; 49(2):376-84. PubMed ID: 18980616 [TBL] [Abstract][Full Text] [Related]
3. Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent. Nemecek J; Nag N; Carlson CM; Schneider JR; Heisey DM; Johnson CJ; Asher DM; Gregori L PLoS One; 2013; 8(10):e78710. PubMed ID: 24205298 [TBL] [Abstract][Full Text] [Related]
4. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Yokoyama T; Takeuchi A; Yamamoto M; Kitamoto T; Ironside JW; Morita M Neurosci Lett; 2011 Jul; 498(2):119-23. PubMed ID: 21565253 [TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832 [TBL] [Abstract][Full Text] [Related]
6. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151 [TBL] [Abstract][Full Text] [Related]
7. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. Moda F; Gambetti P; Notari S; Concha-Marambio L; Catania M; Park KW; Maderna E; Suardi S; Haïk S; Brandel JP; Ironside J; Knight R; Tagliavini F; Soto C N Engl J Med; 2014 Aug; 371(6):530-9. PubMed ID: 25099577 [TBL] [Abstract][Full Text] [Related]
9. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Camacho MV; Telling G; Kong Q; Gambetti P; Notari S Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376 [TBL] [Abstract][Full Text] [Related]
10. Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Jones M; Peden AH; Wight D; Prowse C; Macgregor I; Manson J; Turner M; Ironside JW; Head MW Neuroreport; 2008 Dec; 19(18):1783-6. PubMed ID: 18955905 [TBL] [Abstract][Full Text] [Related]
11. Re-assessment of PrP(Sc) distribution in sporadic and variant CJD. Rubenstein R; Chang B PLoS One; 2013; 8(7):e66352. PubMed ID: 23843953 [TBL] [Abstract][Full Text] [Related]
12. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein. Kobayashi A; Iwasaki Y; Otsuka H; Yamada M; Yoshida M; Matsuura Y; Mohri S; Kitamoto T Acta Neuropathol Commun; 2013 Nov; 1():74. PubMed ID: 24252157 [TBL] [Abstract][Full Text] [Related]
14. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Ironside JW; Head MW Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991 [TBL] [Abstract][Full Text] [Related]